Dimensional Fund Advisors
LSTA icon

Dimensional Fund Advisors’s Lisata Therapeutics LSTA Stock Holding History

Dimensional Fund Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,253
Closed -$26.5K – 3261
2025
Q4 		$26.5K Sell
14,253
-6,694
-32% -$14.9K ﹤0.01% 3231
2025
Q3 		$54.9K Sell
20,947
-4,846
-19% -$12.2K ﹤0.01% 3235
2025
Q2 		$74.3K Buy
25,793
+571
+2% +$1.37K ﹤0.01% 3211
2025
Q1 		$59.3K Sell
25,222
-4
-0% -$11 ﹤0.01% 3246
2024
Q4 		$75.2K Buy
25,226
+7,886
+45% +$22.6K ﹤0.01% 3266
2024
Q3 		$52K Buy
17,340
+4
+0% +$13 ﹤0.01% 3295
2024
Q2 		$60.2K Buy
17,336
+5,639
+48% +$17.2K ﹤0.01% 3296
2024
Q1 		$36.5K Buy
+11,697
New +$34.6K ﹤0.01% 3346
2023
Q3 		– Sell
-14,951
Closed -$55.3K – 3490
2023
Q2 		$55.3K Hold
14,951
– – ﹤0.01% 3398
2023
Q1 		$48.6K Hold
14,951
– – ﹤0.01% 3387
2022
Q4 		$37 Buy
14,951
+2,618
+21% +$9.6K ﹤0.01% 3423
2022
Q3 		$57K Buy
+12,333
New +$89.4K ﹤0.01% 3386
2021
Q2 		– Sell
-4,100
Closed -$119K – 3472
2021
Q1 		$119K Buy
4,100
+2,730
+199% +$82.7K ﹤0.01% 3337
2020
Q4 		$29K Sell
1,370
-807
-37% -$19.2K ﹤0.01% 3337
2020
Q3 		$59K Sell
2,177
-222
-9% -$7.02K ﹤0.01% 3299
2020
Q2 		$64K Sell
2,399
-135
-5% -$3.97K ﹤0.01% 3303
2020
Q1 		$68K Hold
2,534
– – ﹤0.01% 3300
2019
Q4 		$95K Hold
2,534
– – ﹤0.01% 3320
2019
Q3 		$96K Hold
2,534
– – ﹤0.01% 3347
2019
Q2 		$87K Sell
2,534
-173
-6% -$7.69K ﹤0.01% 3404
2019
Q1 		$147K Buy
2,707
+7
+0.3% +$460 ﹤0.01% 3346
2018
Q4 		$144K Hold
2,700
– – ﹤0.01% 3318
2018
Q3 		$239K Hold
2,700
– – ﹤0.01% 3288
2018
Q2 		$262K Buy
2,700
+449
+20% +$31.7K ﹤0.01% 3210
2018
Q1 		$197K Buy
+2,251
New +$156K ﹤0.01% 3231
2016
Q4 		– Sell
-669
Closed -$46K – 3295
2016
Q3 		$46K Buy
+669
New +$53.9K ﹤0.01% 3258
2015
Q1 		– Sell
-23
Closed -$13K – 3370
2014
Q4 		$13K Hold
23
– – ﹤0.01% 3445
2014
Q3 		$19K Sell
23
-2
-8% -$1.75K ﹤0.01% 3448
2014
Q2 		$24K Hold
25
– – ﹤0.01% 3488
2014
Q1 		$26K Hold
25
– – ﹤0.01% 3498
2013
Q4 		$25K Hold
25
– – ﹤0.01% 3458
2013
Q3 		$32K Sell
25
-1
-4% -$1.11K ﹤0.01% 3470
2013
Q2 		$22K Buy
+26
New +$22.8K ﹤0.01% 3490

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $545M AUM 33.4% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Dimensional Fund Advisors's LSTA Position: Q1 2026 in Review

Dimensional Fund Advisors sold out of Lisata Therapeutics (LSTA) in Q1 2026, closing a stake of 14,253 shares — an estimated $26.5K sold.

Dimensional Fund Advisors first reported a position in LSTA in Q2 2013 and held it in 33 quarters. The position peaked at $262K in Q2 2018. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Dimensional Fund Advisors reported no remaining Lisata Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Dimensional Fund Advisors sold 14,253 Lisata Therapeutics shares in Q1 2026, an estimated $26.5K.
  • Dimensional Fund Advisors first reported a position in Lisata Therapeutics in Q2 2013 and held it in 33 quarters.
  • Dimensional Fund Advisors's Lisata Therapeutics position peaked at $262K in Q2 2018.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.